Skip to main content

UBS Group AG

Position in TNGX — Tango Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in TNGX

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$14,630,443
+$5,854,987 QoQ
Shares Held
699,352
-29.4% QoQ
Ownership
0.483%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
16 quarters on record
Voting authority Sole 99.76077854928562.ToString("F0")% Shared 0.ToString("F0")% None 0.2392214507143756.ToString("F0")%

Common Shares in TNGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. TNGX ranks #84 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TNGX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $14,630,443 699,352
2025-12-31 $8,775,456 990,458
2025-09-30 $1,348,015 160,478
2025-06-30 $1,418,762 277,102
2025-03-31 $210,068 153,335
2024-12-31 $1,280,721 414,473
2024-09-30 $3,394,398 440,831
2024-06-30 $1,298,282 151,315
2024-03-31 $1,256,314 158,226
2023-09-30 $348,924 30,988
2023-06-30 $103,368 31,135
2023-03-31 $80,943 20,492
2022-12-31 $119,342 16,461
2022-06-30 $87,089 19,225
2022-03-31 $15,539 2,050
2021-12-31 $28,268 2,584